학술논문
Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
Document Type
Article
Author
Source
In Blood Advances 28 March 2023 7(6):987-996
Subject
Language
ISSN
2473-9529